<p>Influence of <em>CYP2D6, CYP3A5, ABCB1, APOE</em> polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer’s disease and vascular dementia</p>
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.